Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: E. Graphs who wrote (598)	2/21/1998 7:52:00 PM
From: Dauntless	Respond to of 834

E. Graphs - you know me too well. I remain, VERY LONG TXB If the FDA approval does indeed take until the end of 2nd qtr. I think we may see a slight decline. When that happens, however, it will rocket.

To: E. Graphs who wrote (598)	2/22/1998 7:08:00 AM
From: X. Fang	Read Replies (2) \| Respond to of 834

Technically speaking, It's unlikely that TXB will be hold back by $7 1/2. On the long chart, the initial resist is at 8 1/4 to 8 3/4 level. The stock has been preparing for this break out since October, 1997. We might see some consolidation once it reaches 8 1/2. But it should be a very short one before it test $10 since FDA approval is only 4-5 month away. I believe that FAD's approval will push this one above $15, at lease on intra-day base. The old all-time intra-day high was 7 1/4, it just does make any sense that we stop at 7 1/2 after almost a year. Take a look of this weekly chart and MACD indicator, you will agree with me, bigcharts.com Sean